IMPACT OF LNC RNA-NEAT1 ON MULTIPLE DRUG RESISTANCE IN CHRONIC LYMPHOCYTIC LEUKEMIA
Alya Ezzat Mohammed*, Magdy Mahmoud Mohamed, Nashwa Nagy El Khazragy and
Nour Mohamed Abd El-Kader
ABSTRACT
The biological impact and therapeutic potential of long non-coding RNAs (lncRNAs) in chronic lymphocytic leukemia (CLL) remain an area of concern and research. Many studies have found that lncRNAs play a role in cancer progression as well as chemotherapy resistance. Herein, we investigated the impact of lncRNA NEAT1 on multiple drug resistance in CLL. We examined NEAT1 expression in B-CLL patients and in normal B-cells. This study aimed to determine the NEAT1 expression and its correlation with multiple-drug resistance (ATP-binding cassette transporter A3 ABCA3) gene expression in CLL patients using quantitative real-time polymerase chain reaction (qRT-PCR). Our results showed that NEAT1 expression was significantly lower in CLL patients compared to healthy controls (P-value = 0.016). Our results also showed a significant correlation between the expression levels of NEAT1 and ABCA3 genes in CLL patients (P-value < 0.05).
[Full Text Article] [Download Certificate]